You seem to have a position in virtually every stock that’s discussed here. (Perhaps you ought to enumerate the biotech stocks you do not own )
>The results are not Ok. They are very good though I don't class them as excellent.<
LOL. Maybe OK is a more positive characterization in my lexicon than it is in yours. I said COLY’s results were “OK, but not spectacular” and that doesn’t seem inconsistent with your view.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”